Frontiers in Nutrition,
Год журнала:
2021,
Номер
8
Опубликована: Сен. 13, 2021
The
intestinal
epithelial
barrier
(IEB)
is
one
of
the
largest
interfaces
between
environment
and
internal
milieu
body.
It
essential
to
limit
passage
harmful
antigens
microorganisms
and,
on
other
side,
assure
absorption
nutrients
water.
maintenance
this
delicate
equilibrium
tightly
regulated
as
it
for
human
homeostasis.
Luminal
solutes
ions
can
pass
across
IEB
via
two
main
routes:
transcellular
pathway
or
paracellular
pathway.
Tight
junctions
(TJs)
are
a
multi-protein
complex
responsible
regulation
permeability.
TJs
control
through
have
key
role
in
maintaining
integrity.
Several
factors,
including
cytokines,
gut
microbiota,
dietary
components
known
regulate
TJs.
Gut
microbiota
participates
several
functions
modulation
cells
immune
system
release
metabolites,
such
short-chain
fatty
acids
(SCFAs).
Mediators
released
by
induce
cell
damage
dysfunction.
subsequent
disruption
allows
into
mucosa
leading
further
inflammation.
Growing
evidence
indicates
that
dysbiosis,
activation,
dysfunction
diseases,
irritable
bowel
syndrome
(IBS),
inflammatory
disease
(IBD),
gluten-related
conditions.
Here
we
summarize
interplay
mucosal
their
involvement
IBS,
IBD,
disorders.
International Journal of Molecular Sciences,
Год журнала:
2019,
Номер
20(3), С. 649 - 649
Опубликована: Фев. 2, 2019
Interleukin
(IL)-18
was
originally
discovered
as
a
factor
that
enhanced
IFN-γ
production
from
anti-CD3-stimulated
Th1
cells,
especially
in
the
presence
of
IL-12.
Upon
stimulation
with
Ag
plus
IL-12,
naïve
T
cells
develop
into
IL-18
receptor
(IL-18R)
expressing
which
increase
response
to
stimulation.
Therefore,
IL-12
is
commitment
induces
development
cells.
In
contrast,
proinflammatory
cytokine
facilitates
type
1
responses.
However,
without
but
IL-2,
stimulates
NK
CD4+
NKT
and
established
produce
IL-3,
IL-9,
IL-13.
Furthermore,
together
mast
basophils
IL-4,
IL-13,
chemical
mediators
such
histamine.
various
cell
types
has
pleiotropic
functions.
member
IL-1
family
cytokines.
demonstrates
unique
function
by
binding
specific
expressed
on
this
review
article,
we
will
focus
features
health
disease
experimental
animals
humans.
International Journal of Pharmaceutics,
Год журнала:
2017,
Номер
532(1), С. 555 - 572
Опубликована: Сен. 14, 2017
Mucus
is
a
selective
barrier
to
particles
and
molecules,
preventing
penetration
the
epithelial
surface
of
mucosal
tissues.
Significant
advances
in
transmucosal
drug
delivery
have
recently
been
made
emphasized
that
an
understanding
basic
structure,
viscoelastic
properties,
interactions
mucus
great
value
design
efficient
systems.
Mucins,
primary
non-aqueous
component
mucus,
are
polymers
carrying
complex
heterogeneous
structure
with
domains
undergo
variety
molecular
interactions,
such
as
hydrophilic/hydrophobic,
hydrogen
bonds
electrostatic
interactions.
These
properties
directly
relevant
numerous
mucin-associated
diseases,
well
delivering
drugs
across
barrier.
Therefore,
this
review
we
discuss
regional
differences
composition,
physicochemical
pore
size,
viscoelasticity,
pH,
ionic
strength.
factors
also
discussed
respect
changes
function
disease
state.
Collectively,
seeks
provide
state
art
roadmap
for
researchers
who
must
contend
critical
delivery.
Advanced Drug Delivery Reviews,
Год журнала:
2016,
Номер
106, С. 256 - 276
Опубликована: Авг. 4, 2016
In
this
contribution,
we
review
the
molecular
and
physiological
barriers
to
oral
delivery
of
peptides
nanoparticles.
We
discuss
opportunities
predictivity
various
in
vitro
systems
with
special
emphasis
on
human
intestine
Ussing
chambers.
First,
constraints
peptide
absorption
are
discussed.
Then
examined.
These
include
gastric
intestinal
environment,
mucus
barrier,
tight
junctions
between
epithelial
cells,
enterocytes
epithelium,
subepithelial
tissue.
Recent
data
from
proteome
studies
used
provide
information
about
protein
expression
profiles
different
nanoparticle
absorption.
Strategies
that
have
been
employed
increase
across
each
Special
consideration
is
given
attempts
at
utilizing
endogenous
transcytotic
pathways.
To
reliably
translate
or
permeability
vivo
situation
a
subject,
experimental
system
needs
realistically
capture
central
aspects
mentioned
barriers.
Therefore,
characteristics
common
cell
culture
discussed
compared
those
tissues.
Attempts
use
tissue
models
for
vitro–in
extrapolation
reviewed.
Microorganisms,
Год журнала:
2021,
Номер
9(2), С. 353 - 353
Опубликована: Фев. 11, 2021
The
microbiome
plays
an
important
role
in
a
wide
variety
of
skin
disorders.
Not
only
is
the
altered,
but
also
surprisingly
many
diseases
are
accompanied
by
altered
gut
microbiome.
key
regulator
for
immune
system,
as
it
aims
to
maintain
homeostasis
communicating
with
tissues
and
organs
bidirectional
manner.
Hence,
dysbiosis
and/or
associated
response,
promoting
development
diseases,
such
atopic
dermatitis,
psoriasis,
acne
vulgaris,
dandruff,
even
cancer.
Here,
we
focus
on
associations
between
microbiome,
diet,
metabolites,
responses
pathologies.
This
review
describes
exhaustive
list
common
conditions
well
current
body
evidence
dysbiosis,
dietary
links,
their
interplay
conditions.
An
enhanced
understanding
local
including
underlying
mechanisms
necessary
shed
light
microbial
involvement
human
develop
new
therapeutic
approaches.
Internal and Emergency Medicine,
Год журнала:
2023,
Номер
19(2), С. 275 - 293
Опубликована: Июль 28, 2023
Abstract
The
intestine
is
the
largest
interface
between
internal
body
and
external
environment.
intestinal
barrier
a
dynamic
system
influenced
by
composition
of
microbiome
activity
intercellular
connections,
regulated
hormones,
dietary
components,
inflammatory
mediators,
enteric
nervous
(ENS).
Over
years,
it
has
become
increasingly
evident
that
maintaining
stable
crucial
to
prevent
various
potentially
harmful
substances
pathogens
from
entering
Disruption
referred
as
'leaky
gut'
or
leaky
gut
wall
syndrome
seems
be
characterized
release
bacterial
metabolites
endotoxins,
such
lipopolysaccharide
(LPS),
into
circulation.
This
condition,
mainly
caused
infections,
oxidative
stress,
high-fat
diet,
exposure
alcohol
chronic
allergens,
dysbiosis,
appear
highly
connected
with
development
and/or
progression
several
metabolic
autoimmune
systemic
diseases,
including
obesity,
non-alcoholic
fatty
liver
disease
(NAFLD),
neurodegeneration,
cardiovascular
disease,
bowel
type
1
diabetes
mellitus
(T1D).
In
this
review,
starting
description
mechanisms
enable
homeostasis
analyzing
relationship
complex
ecosystem
pathological
conditions,
we
explore
role
in
driving
inflammation,
also
shedding
light
on
current
future
therapeutic
interventions.
Objective
Programmed
death
1
and
its
ligand
(PD-1/PD-L1)
immunotherapy
is
promising
for
late-stage
lung
cancer
treatment,
however,
the
response
rate
needs
to
be
improved.
Gut
microbiota
plays
a
crucial
role
in
sensitisation
Panax
ginseng
has
been
shown
possess
immunomodulatory
potential.
In
this
study,
we
aimed
investigate
whether
combination
treatment
of
polysaccharides
(GPs)
αPD-1
monoclonal
antibody
(mAb)
could
sensitise
by
modulating
gut
microbiota.
Design
Syngeneic
mouse
models
were
administered
GPs
mAb,
sensitising
antitumour
effects
therapy
on
assessed
faecal
transplantation
(FMT)
16S
PacBio
single-molecule
real-time
(SMRT)
sequencing.
To
assess
immune-related
metabolites,
metabolomics
analysis
plasma
samples
was
performed.
Results
We
found
increased
mAb
increasing
microbial
metabolites
valeric
acid
decreasing
L-kynurenine,
as
well
ratio
Kyn/Trp,
which
contributed
suppression
regulatory
T
cells
induction
eff
after
treatment.
Besides,
indicated
that
abundance
Parabacteroides
distasonis
Bacteroides
vulgatus
higher
responders
anti-PD-1
blockade
than
non-responders
clinic.
Furthermore,
sensitised
PD-1
inhibitor
mice
receiving
microbes
FMT
from
six
reshaping
towards
responders.
Conclusion
Our
results
demonstrate
combined
with
may
new
strategy
non-small
cell
patients
immunotherapy.
The
can
used
novel
biomarker
predict
International Journal of Environmental Research and Public Health,
Год журнала:
2021,
Номер
18(23), С. 12836 - 12836
Опубликована: Дек. 6, 2021
The
intestinal
mucosa
provides
a
selective
permeable
barrier
for
nutrient
absorption
and
protection
from
external
factors.
It
consists
of
epithelial
cells,
immune
cells
their
secretions.
gut
microbiota
participates
in
regulating
the
integrity
function
homeostatic
balance.
Pathogens,
xenobiotics
food
can
disrupt
barrier,
promoting
systemic
inflammation
tissue
damage.
Genetic
factors
predispose
individuals
to
dysfunction,
changes
composition
are
central
this
process.
progressive
identification
these
has
led
development
concept
‘leaky
syndrome’
‘gut
dysbiosis’,
which
underlie
relationship
between
impairment,
metabolic
diseases
autoimmunity.
Understanding
mechanisms
underlying
process
is
an
intriguing
subject
research
diagnosis
treatment
various
extraintestinal
diseases.